Effect of Small Versus Large Epidural Needles on Postdural Puncture Headache Study

June 8, 2022 updated by: Dr. Pamela Angle, Sunnybrook Health Sciences Centre

Randomized Controlled Trial Examining the Effect of Small Versus Large Tuohy-type Epidural Needles on the Incidence and Severity of Postdural Puncture Headache

The purpose of this study is to determine the effect of 19g versus =>18g traditional Tuohy-type epidural needles on the incidence and severity of postdural puncture headache (PDPH).

Study Overview

Detailed Description

A headache is the most significant complication of dural puncture during epidural placement. This complication leads to longer hospital stays and many repeated visits to hospital for management. Women suffering from severe postdural puncture headache (PDPH) are often bedridden and unable to care for themselves or their babies.The efficacy of epidural blood patch as a "gold standard" therapy is over-estimated by the earlier, poor quality studies. The prevalence of dural puncture during epidural anesthesia using current techniques ranges from 0.03 to 6% in the literature. Of these patients, 70 to 80% will suffer from moderate to severe PDPH. Avoidance of dural puncture is always the goal. However, complete avoidance is unlikely using current techniques of needle placement. This study proposes another method of prevention (i.e., reducing the gauge of the epidural needles if it is shown to be suitable for continuous infusion in adults). Most of the risk factors for developing PDPH cannot be changed (e.g., younger age, female sex, low body mass index, history of migraines). However, epidural needle gauge is a modifiable risk factor. Evidence suggests that the use of smaller gauge epidural needles, like spinal needles, have the potential to reduce the incidence and severity of PDPH.

Study Type

Interventional

Enrollment (Actual)

1081

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • Vancouver, British Columbia, Canada, V6H 3N1
        • British Columbia Women's Hospital and Health Centre
    • Nova Scotia
      • Halifax, Nova Scotia, Canada, B3J 3G9
        • IWK Health Centre
    • Ontario
      • London, Ontario, Canada, N6A 4V2
        • St. Joseph's Hospital
      • Toronto, Ontario, Canada, M5S 1B2
        • Sunnybrook Health Sciences Centre at Women's College Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • American Society of Anesthesiologists status 1 to 2
  • Must have provided written informed consent = or < 6cm cervical dilation
  • Fetus 37 to 42 weeks gestation
  • Must be able to read and write English well enough to provide written informed consent

Exclusion Criteria:

  • BMI = or > 40
  • Multiple gestation pregnancy
  • Known contraindications to use of epidural analgesia
  • Pregnancy-induced hypertension
  • Investigator concern for maternal or neonatal welfare
  • Receipt of spinal or epidural anesthesia within 14 days of labour epidural request
  • Women with chronic headaches (defined as headaches that occur 15 or more days per month for more than 3 months)
  • Already participated in study
  • History of narcotic abuse

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1
19g needle, 23g catheter
Patients in the experimental group will receive a 23g 90cm adult length epidural catheter placed via a 19g Tuohy epidural needle (SIMS Portex, Hythe, UK). The 19g Tuohy needle is a standard 3½ inch length.
Other Names:
  • Health Canada Health Protection Branch (HPB) Licence # 6832
  • Smith's Medical epidural mini-kits 100/391/190
Active Comparator: 2
traditional =>18g needle
Patients in the control arm will receive a traditional large gauge (16g, 17g or 18g Tuohy or Hustead) epidural needle and a traditional epidural catheter. Two control needles and two control catheters will be designated apriori by each institution for use in the study.
Other Names:
  • Hustead
  • Tuohy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Incidence of postdural puncture headache
Time Frame: within the first 14 days of epidural placement
within the first 14 days of epidural placement

Secondary Outcome Measures

Outcome Measure
Time Frame
PDPH characteristics (quality, distribution, postural versus non-postural nature, associated symptoms)
Time Frame: within first 14 days post-epidural placement, and if necessary, up to 1 year post-epidural placement
within first 14 days post-epidural placement, and if necessary, up to 1 year post-epidural placement
Severity of pain related to PDPH
Time Frame: within first 14 days post-epidural placement, and if necessary, up to 1 year post-epidural placement
within first 14 days post-epidural placement, and if necessary, up to 1 year post-epidural placement
Degree of dysfunction and disability related to PDPH symptoms
Time Frame: within first 14 days post-epidural placement, and if necessary, up to 1 year post-epidural placement
within first 14 days post-epidural placement, and if necessary, up to 1 year post-epidural placement
Duration of PDPH-related symptoms
Time Frame: within first 14 days post-epidural placement, and if necessary, up to 1 year post-epidural placement
within first 14 days post-epidural placement, and if necessary, up to 1 year post-epidural placement
Pain and pain relief (first and second stage labor analgesia following epidural placement and overall pain relief) as rated by the patient, compared between groups
Time Frame: within 24 hours of epidural placement
within 24 hours of epidural placement
Incidence of persistent PDPH symptoms between groups
Time Frame: at 6 weeks post-epidural placement
at 6 weeks post-epidural placement
Number and timing of epidural blood patches received, total number of epidural blood patches received until symptom resolution
Time Frame: within the first 6 weeks of epidural placement
within the first 6 weeks of epidural placement
Risk of delayed block failure for continuous labour analgesia in patients receiving a 19g Tuohy epidural needle and 23g catheter
Time Frame: after first 30 minutes of successful initiation (requiring epidural reinsertion)
after first 30 minutes of successful initiation (requiring epidural reinsertion)
Risk of requiring use of an alternative method of anesthesia for operative delivery in patients receiving successful epidural initiation with a 19g Tuohy epidural needle and a 23g catheter
Time Frame: during labour and delivery
during labour and delivery
Incidence of significant adverse events in each group
Time Frame: up to 1 year post-epidural placement
up to 1 year post-epidural placement
Patient ratings of overall pain relief compared between groups
Time Frame: during labour and delivery
during labour and delivery
Anesthesiologist satisfaction with the 19g Tuohy epidural needle and 23g catheter compared with traditional Tuohy type epidural needles and traditional catheters
Time Frame: during labour and delivery
during labour and delivery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pamela J Angle, MD, MSc, Women's College Hospital at Sunnybrook Health Sciences Centre

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2007

Primary Completion (Actual)

December 1, 2009

Study Completion (Actual)

December 1, 2009

Study Registration Dates

First Submitted

August 29, 2006

First Submitted That Met QC Criteria

August 30, 2006

First Posted (Estimate)

August 31, 2006

Study Record Updates

Last Update Posted (Actual)

June 9, 2022

Last Update Submitted That Met QC Criteria

June 8, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post-Dural Puncture Headache

Clinical Trials on 19g Tuohy-type epidural needle, 23g catheter

Subscribe